Newcelx Ltd (NCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NCEL | CMMB | PLRZ | ||
| Company | Newcelx Ltd | Chemomab Therapeutics Ltd ADR | Polyrizon Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.97 | 2.27 | 11.89 | ||
| High | 3.09 | 2.34 | 12.47 | ||
| Low | 2.48 | 2.01 | 10.70 | ||
| Latest | 2.50 | 2.06 | 11.82 | ||
| Change | -0.41 | -0.16 | -0.79 | ||
| % Change | -14.09% | -7.21% | -6.26% | ||
| Volume | 125,127 | 167,144 | 183,974 | ||
| 20-Day Average Volume | 88,776 | 97,487 | 9,559,127 | ||
| Previous Close | 2.91 | 2.22 | 12.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.55 | 2.50 | 7.46 | ||
| 20-Day Raw Stochastic | 1.01% | 5.96% | 58.36% | ||
| 20-Day Relative Strength | 27.22 | 34.93 | 61.47 | ||
| Weighted Alpha | -84.07 | -71.37 | -88.86 | ||
| Today's Opinion | 100% Sell | 100% Sell | 40% Buy | ||
| Previous Opinion | 100% Sell | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 88% Sell | 96% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -35.40% since 12/08/25 | -24.82% since 12/08/25 | +6.97% since 12/08/25 | ||
| Low | 2.48 on 12/15/25 | 2.01 on 12/15/25 | 10.10 on 12/10/25 | ||
| High | 4.70 on 12/10/25 | 2.73 on 12/09/25 | 14.54 on 12/11/25 | ||
| 1-Month | |||||
| %Chg | -28.37% since 11/14/25 | -22.56% since 11/14/25 | +158.60% since 11/14/25 | ||
| Low | 2.48 on 12/15/25 | 2.01 on 12/15/25 | 2.88 on 11/26/25 | ||
| High | 4.70 on 12/10/25 | 2.85 on 11/18/25 | 18.20 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | -88.48% since 09/15/25 | -26.95% since 09/15/25 | +66.95% since 09/15/25 | ||
| Low | 2.48 on 12/15/25 | 2.01 on 12/15/25 | 2.88 on 11/26/25 | ||
| High | 24.60 on 09/29/25 | 3.58 on 10/07/25 | 18.20 on 12/04/25 | ||
| 6-Month | |||||
| %Chg | -89.04% since 06/13/25 | -57.08% since 06/13/25 | +135.93% since 06/13/25 | ||
| Low | 2.48 on 12/15/25 | 2.01 on 12/15/25 | 2.88 on 11/26/25 | ||
| High | 30.80 on 06/30/25 | 5.04 on 06/16/25 | 18.20 on 12/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,265 | 13,664 | 13,136 | ||
| Shares Outstanding, K | 4,558 | 6,155 | 1,042 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -1,980,000 | -13,950,000 | -1,550,000 | ||
| Last Quarter Sales | N/A | 0 | N/A | ||
| Last Quarter Net Income | -5,847,000 | -1,740,000 | N/A | ||
| 60-Month Beta | 0.12 | 0.50 | -4.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/25/20 | -0.36 on 08/14/25 | N/A | ||
| Latest Earnings Date | 01/01/70 | 03/02/26 | 01/01/70 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||